A R Haug
Overview
Explore the profile of A R Haug including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papp L, Spielvogel C, Grubmuller B, Grahovac M, Krajnc D, Ecsedi B, et al.
Eur J Nucl Med Mol Imaging
. 2020 Dec;
48(6):1795-1805.
PMID: 33341915
Purpose: Risk classification of primary prostate cancer in clinical routine is mainly based on prostate-specific antigen (PSA) levels, Gleason scores from biopsy samples, and tumor-nodes-metastasis (TNM) staging. This study aimed...
2.
Leisser A, Lukic K, Nejabat M, Wadsak W, Mitterhauser M, Mayerhofer M, et al.
Nucl Med Biol
. 2019 Oct;
76-77:15-20.
PMID: 31654811
Introduction: Still little is known about factors, influencing the organ uptake of somatostatin receptor (SSTR)-targeting radiopharmaceuticals. The aim of this study was to assess the influence of gender on [Ga]Ga-DOTANOC...
3.
Leisser A, Nejabat M, Hartenbach M, Duan H, Shariat S, Kramer G, et al.
Hell J Nucl Med
. 2018 Jan;
20 Suppl:157.
PMID: 29324927
Objective: We evaluated the impact of pre-therapeutic hematopoiesis on survival, hematotoxicity (HT) and number of Radium (Ra) treatments in patients with metastatic castration-resistant prostate cancer. Subjects And Method: Hemoglobin-levels (Hb),...
4.
Grubmuller B, Baltzer P, dAndrea D, Korn S, Haug A, Hacker M, et al.
Eur J Nucl Med Mol Imaging
. 2017 Oct;
45(2):235-242.
PMID: 29075832
Objective: To evaluate the diagnostic performance of [Ga]Ga-PSMA conjugate 11 positron emission tomography (PSMA-PET) in the early detection of metastases in patients with biochemical recurrence (BCR) after radical prostatectomy (RP)...
5.
Paprottka P, Paprottka K, Walter A, Haug A, Trumm C, Lehner S, et al.
Cardiovasc Intervent Radiol
. 2015 May;
38(4):946-56.
PMID: 25986465
Purpose: To evaluate the safety of radioembolization (RE) with (90)Yttrium ((90)Y) resin microspheres depending on coiling or no-coiling of aberrant/high-risk vessels. Materials And Methods: Early and late toxicity after 566...
6.
Michl M, Haug A, Jakobs T, Paprottka P, Hoffmann R, Bartenstein P, et al.
Oncology
. 2014 Jan;
86(1):24-32.
PMID: 24401529
Objective: To analyze the clinical efficacy of (90)Y radioembolization in liver metastases from pancreatic cancer, to describe treatment toxicities and to identify biomarkers as predictors of outcome. Methods: Data from...
7.
Meinel F, Schramm N, Haug A, Graser A, Reiser M, Rist C
Radiologe
. 2012 May;
52(6):529-36.
PMID: 22618625
Clinical/methodical Issue: Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) has emerged as a very useful imaging modality in the management of colorectal carcinoma. Data from the literature regarding the role of PET/CT...
8.
Klingenstein A, Haug A, Zech C, Schaller U
Cardiovasc Intervent Radiol
. 2012 Apr;
36(1):158-65.
PMID: 22526099
Purpose: To retrospectively evaluate the overall survival, safety, and efficacy of metastatic uveal melanoma patients after radioembolization as salvage therapy. Materials And Methods: Thirteen patients were treated with radioembolization of...
9.
Haug A, Bartenstein P
Internist (Berl)
. 2012 Jan;
53(2):161-6.
PMID: 22231696
The over expression of somatostatin receptors (SSTR) in neuroendocrine tumors (NET) enables diagnosis and targeted therapy using radio-labelled somatostatin analogues. PET with (68)Ga-DOTATATE or (68)Ga-DOTATOC, both with a high affinity...
10.
Uebleis C, Groebner M, von Ziegler F, Becker A, Rischpler C, Tegtmeyer R, et al.
Int J Cardiovasc Imaging
. 2011 Dec;
28(7):1763-74.
PMID: 22147107
There has been a lack of standardized workup guidelines for patients with congenital abnormal origin of a coronary artery from the opposite sinus (ACAOS). We aimed to evaluate the use...